Publicacions en què col·labora amb Gloria González Aseguinolaza (23)

2016

  1. Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function

    OncoImmunology, Vol. 5, Núm. 8

2015

  1. Chronic exposure to IFNα drives medullar lymphopoiesis towards t-cell differentiation in mice

    Haematologica, Vol. 100, Núm. 8, pp. 1014-1022

  2. Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I

    Journal of Hepatology, Vol. 63, Núm. 2, pp. 329-336

2013

  1. Cytokines for the treatment of gastrointestinal cancers: Clinical experience and new perspectives

    Expert Opinion on Investigational Drugs, Vol. 22, Núm. 7, pp. 827-841

2011

  1. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties

    Hepatology, Vol. 53, Núm. 6, pp. 1864-1873

  2. Characterization of woodchuck apolipoprotein A-I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model

    Journal of Medical Virology, Vol. 83, Núm. 7, pp. 1221-1229

  3. Development of a liver-specific tet-on inducible system for AAV vectors and its application in the treatment of liver cancer

    Molecular Therapy, Vol. 19, Núm. 7, pp. 1245-1253

  4. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice

    Gut, Vol. 60, Núm. 3, pp. 341-349

  5. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of Interleukin-12

    Journal of Virology

2010

  1. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis

    Cancer Gene Therapy, Vol. 17, Núm. 1, pp. 20-27

  2. Gene therapy: A pharmacokinetic/pharmacodynamic modelling overview

    Pharmaceutical Research, Vol. 27, Núm. 8, pp. 1487-1497

2009

  1. Advances in interleukin-12 gene therapy for acquired liver diseases

    Current Gene Therapy, Vol. 9, Núm. 2, pp. 62-71

  2. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders

    Human Gene Therapy, Vol. 20, Núm. 8, pp. 908-917

  3. Production of recombinant woodchuck IFNα and development of monoclonal antibodies

    Journal of Interferon and Cytokine Research, Vol. 29, Núm. 2, pp. 75-81

  4. Semi-mechanistic pharmacodynamic modelling of gene expression and silencing processes

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 418-426

  5. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12

    Journal of Virology, Vol. 83, Núm. 6, pp. 2663-2674

2008

  1. Characterization of high-capacity adenovirus production by the quantitative real-time polymerase chain reaction: A comparative study of different titration methods

    Journal of Gene Medicine, Vol. 10, Núm. 10, pp. 1092-1101

2007

  1. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses

    Journal of Medical Virology, Vol. 79, Núm. 5, pp. 522-529

2006

  1. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice

    Hepatology, Vol. 44, Núm. 3, pp. 623-632

  2. Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction

    Human Gene Therapy, Vol. 17, Núm. 6, pp. 601-610